← Back to Search

Vibrotactile Stimulation

skin surface vibration for Parkinson's Disease

N/A
Waitlist Available
Led By Christopher W Hess, MD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-80 and able to provide informed consent.
Have a diagnosis of Parkinson's disease, essential tremor, or cervical dystonia made by a movement disorders specialist.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to immediately after the sham intervention
Awards & highlights

Study Summary

This study is evaluating whether vibration applied to the skin might improve motor control in people with movement disorders.

Eligible Conditions
  • Parkinson's Disease
  • Dystonia
  • Essential Tremor

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to immediately after the sham intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to immediately after the sham intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quantitative Tremor Assessment
Secondary outcome measures
Functional Dexterity Task (FDT)
Reaction time task
Timed-up-and-go (TUG) gait task

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Vibrotactile Intermittent stimulationExperimental Treatment1 Intervention
Intermittent stimulation
Group II: Vibrotactile Continuous stimulationExperimental Treatment1 Intervention
Continuous stimulation
Group III: Vibrotactile ShamPlacebo Group1 Intervention
Sham stimulation

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,333 Previous Clinical Trials
714,551 Total Patients Enrolled
Parkinson's FoundationOTHER
11 Previous Clinical Trials
1,020,844 Total Patients Enrolled
Christopher W Hess, MDPrincipal InvestigatorNorman Fixel Institute for Neurological Diseases, University of Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~12 spots leftby Mar 2025